Filter News
Area of Research
News Topics
- (-) Advanced Reactors (2)
- (-) Biomedical (6)
- 3-D Printing/Advanced Manufacturing (4)
- Artificial Intelligence (12)
- Big Data (1)
- Bioenergy (6)
- Biology (4)
- Biotechnology (1)
- Buildings (1)
- Chemical Sciences (3)
- Climate Change (3)
- Computer Science (32)
- Coronavirus (5)
- Cybersecurity (6)
- Decarbonization (1)
- Energy Storage (5)
- Environment (3)
- Exascale Computing (7)
- Frontier (12)
- Fusion (1)
- Grid (3)
- High-Performance Computing (11)
- Isotopes (3)
- Machine Learning (5)
- Materials (8)
- Materials Science (7)
- Microscopy (5)
- Molten Salt (1)
- Nanotechnology (5)
- National Security (5)
- Neutron Science (8)
- Nuclear Energy (7)
- Partnerships (1)
- Physics (5)
- Quantum Computing (5)
- Quantum Science (10)
- Security (4)
- Simulation (1)
- Space Exploration (3)
- Summit (14)
- Sustainable Energy (5)
- Transformational Challenge Reactor (1)
- Transportation (2)
Media Contacts
Scientists at ORNL used their expertise in quantum biology, artificial intelligence and bioengineering to improve how CRISPR Cas9 genome editing tools work on organisms like microbes that can be modified to produce renewable fuels and chemicals.
ORNL scientists will present new technologies available for licensing during the annual Technology Innovation Showcase. The event is 9 a.m. to 3 p.m. Thursday, June 16, at the Manufacturing Demonstration Facility at ORNL’s Hardin Valley campus.
A team led by Dan Jacobson of Oak Ridge National Laboratory used the Summit supercomputer at ORNL to analyze genes from cells in the lung fluid of nine COVID-19 patients compared with 40 control patients.
A team of researchers has performed the first room-temperature X-ray measurements on the SARS-CoV-2 main protease — the enzyme that enables the virus to reproduce.
Researchers at the Department of Energy’s Oak Ridge National Laboratory are refining their design of a 3D-printed nuclear reactor core, scaling up the additive manufacturing process necessary to build it, and developing methods
OAK RIDGE, Tenn., March 4, 2019—A team of researchers from the Department of Energy’s Oak Ridge National Laboratory Health Data Sciences Institute have harnessed the power of artificial intelligence to better match cancer patients with clinical trials.
The Department of Energy’s Oak Ridge National Laboratory is collaborating with industry on six new projects focused on advancing commercial nuclear energy technologies that offer potential improvements to current nuclear reactors and move new reactor designs closer to deployment.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.